Our Pipeline
We are developing innovative therapies targeting age-related diseases through multiple approaches.
Autophagy
Alzheimer's Disease
Small molecule drug to boost autophagic flux
RTR242
Proof of ConceptPoC
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
iMG
CNS Conditions
iPSC-derived microglial progenitors
RTR888
Proof of ConceptPoC
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
iHSC
Blood Disorders
iPSC-derived hematopoietic stem cells
RTR890
Proof of ConceptPoC
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
Tissue Reprogramming
Osteoarthritis, Age-related Hearing Loss, Alzheimer's Disease
AAV-delivered reprogramming factors for in vivo rejuvenation
Proof of ConceptPoC
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
